OPTASE- glycerin solution/ drops 
Scope Health Inc

----------

Optase Hylo Relief Drops

0.25 % glycerin

Keep out of reach of children.
If swallowed get medical
help or contact a poison
control center right away.

Eye Lubricant

Inactive ingredients:
Borax, Boric Acid, Citric Acid
anhydrous, Sodium Chloride,
Sodium Citrate Dihydrate,
Sodium Hyaluronate, water.

Directions:
Put one or two drops in the
affected eyes as needed.

Warning
• For external use only.
• If solution changes color or
becomes cloudy, do not use.


Stop use and ask doctor if
• You feel eye pain.
• Changes in vision occur.
• Redness or irritation of the eye lasts.
• Condition worsens or lasts
more than 72 hours

Uses
• For use as a lubricant to prevent
further irritation.
• May be used as a protectant against
further irritation.
• To relieve dryness of the eye.

Patient Information Leaflet- Page 1

Instructions for use

Patient Information Leaflet- Page 2

Instructions for use

Optase Hylo Relief

Immediate label

Optase Hylo Relief

OPTASE 
glycerin solution/ drops
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:72972-005
Route of AdministrationOPHTHALMIC
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
GLYCERIN (UNII: PDC6A3C0OX) (GLYCERIN - UNII:PDC6A3C0OX) GLYCERIN0.25 mg  in 1 mL
Inactive Ingredients
Ingredient NameStrength
SODIUM BORATE (UNII: 91MBZ8H3QO)  
SODIUM CHLORIDE (UNII: 451W47IQ8X)  
BORIC ACID (UNII: R57ZHV85D4)  
ANHYDROUS CITRIC ACID (UNII: XF417D3PSL)  
HYALURONATE SODIUM (UNII: YSE9PPT4TH)  
TRISODIUM CITRATE DIHYDRATE (UNII: B22547B95K)  
WATER (UNII: 059QF0KO0R)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:72972-005-011 in 1 BOX02/10/2023
110 mL in 1 BOTTLE, DISPENSING; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM01802/10/2023
Labeler - Scope Health Inc (116778693)
Registrant - Regulatory Matters Consulting (080711165)

Revised: 11/2023
Document Id: 0a7b8968-f55d-85db-e063-6394a90a6e09
Set id: f452a2c4-c869-7bf5-e053-2995a90ac1a0
Version: 2
Effective Time: 20231119
 
Scope Health Inc